CN105232910A - Stone eliminating pills - Google Patents
Stone eliminating pills Download PDFInfo
- Publication number
- CN105232910A CN105232910A CN201510460116.8A CN201510460116A CN105232910A CN 105232910 A CN105232910 A CN 105232910A CN 201510460116 A CN201510460116 A CN 201510460116A CN 105232910 A CN105232910 A CN 105232910A
- Authority
- CN
- China
- Prior art keywords
- tonifying
- raw
- kidney
- borax
- paeoniae alba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses stone eliminating pills. The stone eliminating pills are prepared from 15%-25% of raw endothelium corneum gigeriae galli, 12%-18% of raw radix astragali, 12%-18% of rhizoma anemarrhenae, 10%-15% of radix paeoniae alba, 10%-15% of borax, 9%-11% of mirabilite and 9%-11% of nitre. The stone eliminating pills have efficacies of kidney clearing for detoxifying, kidney nourishing for health improvement, heat clearing, anti-inflammatory action, deficiency tonifying, essence enriching, stone eliminating, urination promoting, urinary tract clearing, lung moistening, liver tonifying, eyesight improving and the like and is effective in improvement of blood circulation, increase of renal blood flow, increase of glomerulus filtering rate, inhibition of glomerulus and renal tubule cell lesions, improvement and protection of glomerulus and renal tubule tissues, kidney boosting, Yang tonifying, deficiency tonifying, essence enriching, kidney tonifying, lung moistening, liver tonifying, eyesight improving and the like.
Description
Technical field
The present invention relates to medical formulation applied technical field, especially a kind of fossil pill makes formula.
Background technology
Human body urinary system comprises kidney, ureter, bladder form with urethra and relevant nervus vasculairs, and main department generates and discharges urine.Because the antibacterials such as escherichia coli invade urinary tract, just cause multiple urinary tract infection, comprise urethritis, cystitis and pyelonephritis etc., wherein urethritis and cystitis are called as lower urinary tract infection, and pyelonephritis is called as upper urinary tract infection.Male genital infection refers to that male reproductive system (urethra, prostate, epididymis, deferent duct, seminal vesicle, testis etc.) is subject to antibacterial, virus or parasitic infection and the disease caused.Male genetic infectious disease is because the invasion infection of outside antibacterial causes mostly, often causes orchitis, epididymitis, prostatitis, seminal vesiculitis, urethritis etc.The pathogen of reproductive tract infection is caused to have gonococcus, tubercule bacillus, virus, mycoplasma, chlamydia trachomatis, infusorian and other non-specific pathogenic bacterium, wherein common with the reproductive tract infection that mycoplasma and chlamydia cause.
But prior art does not have one formula can realize effecting a radical cure above disease, and the present invention is life therefrom.
Summary of the invention
Prior art can not meet the needs of people, and for making up prior art deficiency, the present invention aims to provide a kind of fossil pill and makes formula.
For achieving the above object, the present invention by the following technical solutions: a kind of fossil pill makes formula, makes raw material and comprises live chickens Endothelium corneum, Radix Astragali, the Rhizoma Anemarrhenae, raw Radix Paeoniae Alba, Borax, Mirabilitum and Sal Nitri; Described making proportioning raw materials is: live chickens Endothelium corneum 15% ~ 25%; Radix Astragali 12% ~ 18%; The Rhizoma Anemarrhenae 12% ~ 18%; Raw Radix Paeoniae Alba 10% ~ 15%, Borax 10% ~ 15%; Mirabilitum 9% ~ 11%; Sal Nitri 9% ~ 11%.
Further, described live chickens Endothelium corneum, Radix Astragali, the Rhizoma Anemarrhenae, raw Radix Paeoniae Alba, Borax, Mirabilitum and Sal Nitri make raw material optimum ratio and to make a living Endothelium Corneum Gigeriae Galli 18%; Radix Astragali 16%; The Rhizoma Anemarrhenae 14%; Raw Radix Paeoniae Alba 12%, Borax 12%; Mirabilitum 10%; Sal Nitri 10%.
Compared with prior art, the invention has the beneficial effects as follows: the present invention has " wash kidney toxin expelling, support kidney keep fit ", " heat clearing away antiinflammatory, tonify deficiency benefit essence ", " calculus diuretic, cleaning urinary tract ", the function such as " nourishing kidney lung moistening; tonifying liver improving eyesight ", to improving blood circulation.Increase renal blood flow, improve glomerular filtration rate, control glomerule, renal tubular cell pathological changes, improvement and the successful such as protection glomerule, body tubular tissue and kidney-reinforcing Yang strengthening, tonify deficiency benefit essence, nourishing kidney, lung moistening, tonifying liver, improving eyesight.
Detailed description of the invention
Be clearly and completely described to the technical scheme in the embodiment of the present invention below, obviously, described embodiment is only the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making other embodiments all obtained under creative work prerequisite, belong to the scope of protection of the invention.
A kind of fossil pill makes formula, makes raw material and comprises live chickens Endothelium corneum, Radix Astragali, the Rhizoma Anemarrhenae, raw Radix Paeoniae Alba, Borax, Mirabilitum and Sal Nitri; Described making proportioning raw materials is: live chickens Endothelium corneum 15% ~ 25%; Radix Astragali 12% ~ 18%; The Rhizoma Anemarrhenae 12% ~ 18%; Raw Radix Paeoniae Alba 10% ~ 15%, Borax 10% ~ 15%; Mirabilitum 9% ~ 11%; Sal Nitri 9% ~ 11%.
Further, described live chickens Endothelium corneum, Radix Astragali, the Rhizoma Anemarrhenae, raw Radix Paeoniae Alba, Borax, Mirabilitum and Sal Nitri make raw material optimum ratio and to make a living Endothelium Corneum Gigeriae Galli 18%; Radix Astragali 16%; The Rhizoma Anemarrhenae 14%; Raw Radix Paeoniae Alba 12%, Borax 12%; Mirabilitum 10%; Sal Nitri 10%.
Embodiment: live chickens Endothelium corneum 50g; Radix Astragali 40g; Borax 30g;
Rhizoma Anemarrhenae 40g; Raw Radix Paeoniae Alba 30g; Sal Nitri 25g;
Mirabilitum 25g.
In the present invention: Radix Astragali, golden yellow stilbene nature and flavor are sweet, tepor, return spleen, lung meridian, are QI invigorating key medicine.During clinical practice custom be divided into raw with, processed with honey, wheat bran stir 3 kinds, its drug effect is had nothing in common with each other, and Radix Astragali is used for consolidating superficial resistance, holds in the palm skin ulcer, diuretic etc.; Radix Astragali (processed with Mel) is used for invigorating the spleen and replenishing QI; Parching to brown stilbene is used for replenishing QI to invigorate the spleen.
Borax is more than for nose bleeding, pulmonary tuberculosis, throat paddy thief, sore throat, ulcerative gingivitis etc. have curative effect.
The cloudy pathogenic fire reducing of the Rhizoma Anemarrhenae, moisturizes laxation.Control dysphoria with smothery sensation to quench one's thirst, hectic fever due to YIN-deficiency consumptive fever, cough due to lung-heat, constipation due to dry stool, dysuria.For epidemic febrile disease, the lung excess of the stomach heat syndromes such as the high Sheng of pathogenic heat, high fever, excessive thirst, full and large pulse.
Raw its cold nature of Radix Paeoniae Alba, bitter in the mouth, acid.Function is suppressing the hyperactive liver pain relieving, nourishing blood for regulating menstruation, astringing YIN to stop sweating.Be mainly used in headache dizzy, hypochondriac pain, stomachache, limb pain twin, blood deficiency and yellow complexion, menoxenia, spontaneous perspiration, night sweat.
Mirabilitum purges heat and moisturizes; Clearing heat for detumescence; Hard masses softening and resolving.For excess-heat constipation, constipation due to dry stool, stagnant stomachache, acute appendicitis swells and ache; External treatment acute mastitis, swelling and pain of hemorrhoid.
To those skilled in the art, obviously the invention is not restricted to the details of above-mentioned one exemplary embodiment, and when not deviating from spirit of the present invention or basic feature, the present invention can be realized in other specific forms.Therefore, no matter from which point, all should embodiment be regarded as exemplary, and be nonrestrictive, scope of the present invention is limited by claims instead of above-mentioned explanation, and all changes be therefore intended in the implication of the equivalency by dropping on claim and scope are included in the present invention.Any labelling in claim should be considered as the claim involved by limiting.
The above; be only preferred embodiment of the present invention; not in order to limit the present invention, every above embodiment is done according to technical spirit of the present invention any trickle amendment, equivalently replace and improve, within the protection domain that all should be included in technical solution of the present invention.
Claims (2)
1. fossil pill makes a formula, makes raw material and comprises live chickens Endothelium corneum, Radix Astragali, the Rhizoma Anemarrhenae, raw Radix Paeoniae Alba, Borax, Mirabilitum and Sal Nitri; It is characterized in that: described making proportioning raw materials is: live chickens Endothelium corneum 15% ~ 25%; Radix Astragali 12% ~ 18%; The Rhizoma Anemarrhenae 12% ~ 18%; Raw Radix Paeoniae Alba 10% ~ 15%, Borax 10% ~ 15%; Mirabilitum 9% ~ 11%; Sal Nitri 9% ~ 11%.
2. a kind of fossil pill according to claim 1 makes formula, it is characterized in that: described live chickens Endothelium corneum, Radix Astragali, the Rhizoma Anemarrhenae, raw Radix Paeoniae Alba, Borax, Mirabilitum and Sal Nitri make raw material optimum ratio and to make a living Endothelium Corneum Gigeriae Galli 18%; Radix Astragali 16%; The Rhizoma Anemarrhenae 14%; Raw Radix Paeoniae Alba 12%, Borax 12%; Mirabilitum 10%; Sal Nitri 10%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510460116.8A CN105232910A (en) | 2015-07-23 | 2015-07-23 | Stone eliminating pills |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510460116.8A CN105232910A (en) | 2015-07-23 | 2015-07-23 | Stone eliminating pills |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105232910A true CN105232910A (en) | 2016-01-13 |
Family
ID=55030904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510460116.8A Pending CN105232910A (en) | 2015-07-23 | 2015-07-23 | Stone eliminating pills |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105232910A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101401894A (en) * | 2008-11-25 | 2009-04-08 | 洛阳建辉牡丹应用技术研究中心 | Compound formulation for medicament for diuresis and expelling stone |
| CN101658644A (en) * | 2009-09-16 | 2010-03-03 | 蒋保珍 | Internal administration medicament for treating urolithiasis disease |
| CN104398769A (en) * | 2014-11-29 | 2015-03-11 | 高春娟 | Medicament for treating lithangiuria and preparation method thereof |
-
2015
- 2015-07-23 CN CN201510460116.8A patent/CN105232910A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101401894A (en) * | 2008-11-25 | 2009-04-08 | 洛阳建辉牡丹应用技术研究中心 | Compound formulation for medicament for diuresis and expelling stone |
| CN101658644A (en) * | 2009-09-16 | 2010-03-03 | 蒋保珍 | Internal administration medicament for treating urolithiasis disease |
| CN104398769A (en) * | 2014-11-29 | 2015-03-11 | 高春娟 | Medicament for treating lithangiuria and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 张锡纯: "《医学衷中参西录（合订本）》", 31 October 1974, 河北人民出版社 * |
| 陆拯: "《近代中医珍本集 验方分册》", 31 January 2003, 浙江科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102698121B (en) | Traditional Chinese medicinal composition for treating paradentitis and preparation method thereof and toothpaste | |
| CN102579988B (en) | Traditional Chinese medicine for preventing and treating gingivitis, Chinese herbal medicine tooth powder and preparation method | |
| KR102026535B1 (en) | A cosmetic composition comprising a mixture of natural herbs extracts | |
| CN103520502A (en) | Chinese medicinal preparation for treating gingivitis and preparation method thereof | |
| CN104524337A (en) | Traditional Chinese medicine for treating dental ulcer | |
| CN104069474A (en) | Traditional Chinese medicine composition for treating seborrheic alopecia and preparation method thereof | |
| CN103263654B (en) | Medicine for treating lobar pneumonia and preparation method thereof | |
| CN108635478A (en) | It is a kind of to treat canker sore, pharyngitis, the Chinese medicine composition of tonsillitis and preparation method | |
| CN102038832A (en) | Traditional Chinese medicine for treating dandruff | |
| CN105232910A (en) | Stone eliminating pills | |
| CN103341151B (en) | Traditional Chinese medicine for treating chronic bronchitis | |
| CN103623196B (en) | Traditional Chinese medicine composition for treating yin-deficiency and fire-excess type periodontitis | |
| CN105663575A (en) | Traditional Chinese medicine composition for preventing and treating swine fever and preparation method of traditional Chinese medicine composition | |
| CN1306952C (en) | Chinese traditional medicine for treating chronic pharyngolaryngitis and its preparing process | |
| CN104027741B (en) | A kind of oral medication women Chondromalacia of patella Chinese medicine composition | |
| CN107648494A (en) | One kind treats gingivitis and canker sore Chinese medical collutory and preparation method thereof | |
| CN106266285A (en) | A kind of sterilizing and itch-relieving, the external used medicine of heat-clearing and toxic substances removing | |
| CN105456708A (en) | Drug for treating cheilitis and preparation method thereof | |
| CN104958653A (en) | Traditional Chinese medicine composition for treating tuberculosis | |
| CN106215099A (en) | A kind of medicine treating furuncle carbuncle and preparation method thereof | |
| CN104940112A (en) | Antiseptic and anti-acne traditional Chinese medicine face mask and preparation method thereof | |
| CN106214815A (en) | A kind of pure Traditional Chinese medicine foot bath powder | |
| CN104873861A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN104474320A (en) | Medicine for treating chronic bronchitis and preparation method of medicine | |
| CN104606447A (en) | Traditional Chinese medicine preparation for treating exogenous fever |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160113 |